Sanofi SA (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 203   

Articles published

SNY 52.34 +0.67 (1.30%)
price chart
Stocks Rallied on News- Sanofi (NYSE:SNY), Potash Corp./Saskatchewan ...
Genzyme, a Sanofi SA (ADR) (SNY), declared that after constructive discussions with the FDA the firm aims to resubmit in the Q2 its supplemental Biologics License Application seeking authorization of Lemtrada for the treatment of relapsing forms of ...
Related articles »  
Notable Movers: Incyte Corporation (NASDAQ:INCY), Mylan Inc (NASDAQ:MYL ...
Las Vegas, NV - April 7, 2014 - (TechSonian) - Incyte Corporation (NASDAQ:INCY) reported that a pivotal Phase III trial of ruxolitinib compared to best obtainable therapy in patients with polycythemia vera who are resistant to or intolerant of ...
Related articles »  
Healthcare Unusual volume: IsoRay (NYSEMKT:ISR), CytRx Corporation ...
Sanofi (ADR) (NYSE:SNY) Announces FDA Has Expanded Age Indication of Adacel´┐Ż Tdap Vaccine to Include Persons 10 Years of Age. Sanofi SA (ADR) (NYSE:SNY) weekly performance is 0.56%. On last trading day company shares ended up $52.04.
Related articles »  
Versatile News at Street: Zimmer Holdings (NYSE:ZMH), Sanofi (NYSE:SNY), Eli ...
Sanofi SA (ADR) (NYSE:SNY) [Trend Analysis] dropped -0.84%, closing the day at $51.84 in last regular trading while in after hours trading shares moved up 0.10%.
Amgen Takes Lead In Cholesterol Drug Race
Regeneron, which is partnered with Sanofi SA (ADR) (SNY), plans to conduct 12 studies on its drug in the category while Pfizer is working on understanding the long term benefits of its drug with a program comprising 22,000 patients.
Related articles »  
News In Focus: Sanofi (NYSE:SNY), UTi Worldwide (NASDAQ:UTIW), North ...
Sanofi SA (ADR) (NYSE:SNY) [Trend Analysis] reported the gain of +0.58% and closed at $52.98 with the total average volume of 1.30 million shares.
Related articles »  
Uptrend Stocks: HSBC Holdings (NYSE:HSBC), Intel (NASDAQ:INTC), Netflix ...
Genzyme, a Sanofi SA's (ADR) (SNY) company, earlier reported that the FDA permitted revised prescribing information for the use of Thyrogen (thyrotropin alfa for injection) to widen the dose range of radioiodine at what time used for thyroid remnant ...
Related articles »  
Stocks Buzz - DaVita HealthCare Partners Inc (NYSE:DVA), Thermo Fisher ...
Las Vegas, NV - 14 April 2014 - (Tech Sonian) - One of the nation's largest and most innovative health care communities, DaVita HealthCare Partners Inc (NYSE:DVA), reported that Javier Rodriguez will move from president to CEO of DaVita's Kidney Care ...
Related articles »  
Eye-Catching Stocks - Neogen Corporation (NEOG), StrikeForce Technologies ...
Las Vegas, NV - March 26, 2014 - (TechSonian) - Neogen Corp. (NEOG) declared that its Q3 net income attributable to the company edged down to $6.575 million from the prior year's $6.652 million.
Related articles »